von Hippel-Lindau tumor suppressor protein represses platelet-derived growth factor B-chain gene expression via the Sp1 binding element in the proximal PDGF-B promoter
VHL is the causative gene for von Hippel‐Lindau disease and sporadic clear cell renal cancer. It has been shown that pVHL can suppress the expression of certain genes that are overexpressed in renal carcinomas. One such gene is that encoding the potent mitogen and chemoattractant, platelet‐derived g...
Saved in:
Published in | Journal of cellular biochemistry Vol. 85; no. 3; pp. 490 - 495 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
New York
Wiley Subscription Services, Inc., A Wiley Company
2002
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | VHL is the causative gene for von Hippel‐Lindau disease and sporadic clear cell renal cancer. It has been shown that pVHL can suppress the expression of certain genes that are overexpressed in renal carcinomas. One such gene is that encoding the potent mitogen and chemoattractant, platelet‐derived growth factor B‐chain (PDGF‐B). The regulatory mechanisms underlying pVHL suppression of PDGF‐B expression, however, are completely unknown. This understanding would shed vital light on the control of growth factor gene expression by this tumor suppressor. Here we report that pVHL can repress both endogenous steady‐state PDGF‐B mRNA expression and PDGF‐B promoter‐dependent transcription in WKY12‐22 cells. Transient transfection analysis utilizing PDGF‐B promoter‐chloramphenicol acetyl transferase (CAT) reporter constructs revealed that pVHL inhibition of PDGF‐B expression is mediated via the Sp1‐binding element in the proximal region of the PDGF‐B promoter. Recent studies have demonstrated a physical interaction between pVHL and Sp1, which activates the PDGF‐B promoter. We show that Sp1 can rescue PDGF‐B promoter activity and endogenous PDGF‐B mRNA expression from pVHL repression. These findings thus demonstrate a pivotal role for Sp1 in pVHL inhibition of PDGF‐B transcription. J. Cell. Biochem. 85: 490–495, 2002. © 2002 Wiley‐Liss, Inc. |
---|---|
AbstractList | VHL is the causative gene for von Hippel‐Lindau disease and sporadic clear cell renal cancer. It has been shown that pVHL can suppress the expression of certain genes that are overexpressed in renal carcinomas. One such gene is that encoding the potent mitogen and chemoattractant, platelet‐derived growth factor B‐chain (PDGF‐B). The regulatory mechanisms underlying pVHL suppression of PDGF‐B expression, however, are completely unknown. This understanding would shed vital light on the control of growth factor gene expression by this tumor suppressor. Here we report that pVHL can repress both endogenous steady‐state PDGF‐B mRNA expression and PDGF‐B promoter‐dependent transcription in WKY12‐22 cells. Transient transfection analysis utilizing PDGF‐B promoter‐chloramphenicol acetyl transferase (CAT) reporter constructs revealed that pVHL inhibition of PDGF‐B expression is mediated via the Sp1‐binding element in the proximal region of the PDGF‐B promoter. Recent studies have demonstrated a physical interaction between pVHL and Sp1, which activates the PDGF‐B promoter. We show that Sp1 can rescue PDGF‐B promoter activity and endogenous PDGF‐B mRNA expression from pVHL repression. These findings thus demonstrate a pivotal role for Sp1 in pVHL inhibition of PDGF‐B transcription. J. Cell. Biochem. 85: 490–495, 2002. © 2002 Wiley‐Liss, Inc. VHL is the causative gene for von Hippel-Lindau disease and sporadic clear cell renal cancer. It has been shown that pVHL can suppress the expression of certain genes that are overexpressed in renal carcinomas. One such gene is that encoding the potent mitogen and chemoattractant, platelet-derived growth factor B-chain (PDGF-B). The regulatory mechanisms underlying pVHL suppression of PDGF-B expression, however, are completely unknown. This understanding would shed vital light on the control of growth factor gene expression by this tumor suppressor. Here we report that pVHL can repress both endogenous steady-state PDGF-B mRNA expression and PDGF-B promoter-dependent transcription in WKY12-22 cells. Transient transfection analysis utilizing PDGF-B promoter-chloramphenicol acetyl transferase (CAT) reporter constructs revealed that pVHL inhibition of PDGF-B expression is mediated via the Sp1-binding element in the proximal region of the PDGF-B promoter. Recent studies have demonstrated a physical interaction between pVHL and Sp1, which activates the PDGF-B promoter. We show that Sp1 can rescue PDGF-B promoter activity and endogenous PDGF-B mRNA expression from pVHL repression. These findings thus demonstrate a pivotal role for Sp1 in pVHL inhibition of PDGF-B transcription. Abstract VHL is the causative gene for von Hippel‐Lindau disease and sporadic clear cell renal cancer. It has been shown that pVHL can suppress the expression of certain genes that are overexpressed in renal carcinomas. One such gene is that encoding the potent mitogen and chemoattractant, platelet‐derived growth factor B‐chain (PDGF‐B). The regulatory mechanisms underlying pVHL suppression of PDGF‐B expression, however, are completely unknown. This understanding would shed vital light on the control of growth factor gene expression by this tumor suppressor. Here we report that pVHL can repress both endogenous steady‐state PDGF‐B mRNA expression and PDGF‐B promoter‐dependent transcription in WKY12‐22 cells. Transient transfection analysis utilizing PDGF‐B promoter‐chloramphenicol acetyl transferase (CAT) reporter constructs revealed that pVHL inhibition of PDGF‐B expression is mediated via the Sp1‐binding element in the proximal region of the PDGF‐B promoter. Recent studies have demonstrated a physical interaction between pVHL and Sp1, which activates the PDGF‐B promoter. We show that Sp1 can rescue PDGF‐B promoter activity and endogenous PDGF‐B mRNA expression from pVHL repression. These findings thus demonstrate a pivotal role for Sp1 in pVHL inhibition of PDGF‐B transcription. J. Cell. Biochem. 85: 490–495, 2002. © 2002 Wiley‐Liss, Inc. |
Author | Rafty, Louise A. Khachigian, Levon M. |
Author_xml | – sequence: 1 givenname: Louise A. surname: Rafty fullname: Rafty, Louise A. organization: Centre for Thrombosis and Vascular Research, University of New South Wales, Australia – sequence: 2 givenname: Levon M. surname: Khachigian fullname: Khachigian, Levon M. email: L.Khachigian@unsw.edu.au organization: Centre for Thrombosis and Vascular Research, University of New South Wales, Australia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/11967988$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kctuEzEYhS1URNOWBS-AvEJiYWqPZ8bjJQkkbRUBakGwszyefxKXudX2pOkT8Zo4F2DFyrfvnGP7nKGTru8AoVeMvmOUJpf3powTliXP0IRRKUiap-kJmlDBKUk4S07Rmff3lFIpefICnTImcyGLYoJ-bfoOX9lhgIYsbVfpEYex7R324zA48D5OB9cHsB12sN8Bj4dGB2ggkAqc3UCFV65_DGtcaxOiYErMWkfBCjrAsN2rbMzZWI3DGvDdwHAZw2y3wtGmhS7giO-OYtbWtrrBXz4s5mS6W7cx3V2g57VuPLw8jufo2_zj19kVWX5eXM_eL4nhmUxInUJp6oyWJcuMBMEMlZoKmUMlTFkJqeOzeZ1LzvO8MqUscp1W8edkwqq8YPwcvTn4xuCHEXxQrfUGmkZ30I9eCSZYkTAZwbcH0Ljeewe1Gly8uHtSjKpdKyq2ovatRPb10XQsW6j-kccaInB5AB5tA0__d1I3s-kfS3JQWB9g-1eh3U-VCy4y9f3TQv2Qt8k8nS3VLf8NgJqqdQ |
CitedBy_id | crossref_primary_10_1038_sj_onc_1210474 crossref_primary_10_1158_1535_7163_MCT_08_0013 crossref_primary_10_1002_path_2689 crossref_primary_10_1111_febs_13148 crossref_primary_10_1152_ajplung_00026_2003 crossref_primary_10_1074_jbc_M109_002691 crossref_primary_10_1159_000075346 crossref_primary_10_1002_ijc_31196 crossref_primary_10_1038_nrc2502 crossref_primary_10_1038_nrc3844 crossref_primary_10_1016_j_bone_2019_03_006 crossref_primary_10_1016_j_bbcan_2009_01_001 |
Cites_doi | 10.1073/pnas.93.5.1770 10.1074/jbc.271.20.11792 10.1074/jbc.271.24.14584 10.1126/science.284.5413.455 10.1128/MCB.17.9.5629 10.1126/science.8493574 10.1074/jbc.271.6.3025 10.1093/hmg/3.8.1303 10.1128/MCB.19.2.1486 10.1016/S0959-437X(00)00152-0 10.1073/pnas.93.20.10595 10.1093/hmg/3.12.2169 10.1016/S0021-9258(17)31695-2 10.1074/jbc.273.41.26277 10.1073/pnas.92.14.6459 10.1006/bbrc.1999.1767 |
ContentType | Journal Article |
Copyright | Copyright © 2002 Wiley‐Liss, Inc. Copyright 2002 Wiley-Liss, Inc. |
Copyright_xml | – notice: Copyright © 2002 Wiley‐Liss, Inc. – notice: Copyright 2002 Wiley-Liss, Inc. |
DBID | BSCLL CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1002/jcb.10152 |
DatabaseName | Istex Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Biology |
EISSN | 1097-4644 |
EndPage | 495 |
ExternalDocumentID | 10_1002_jcb_10152 11967988 JCB10152 ark_67375_WNG_X9R2F4CL_R |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: NSW State Department of Health – fundername: National Health and Medical Research Council of Australia |
GroupedDBID | --- -~X .3N .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 31~ 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACIWK ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHMBA AIAGR AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AUFTA AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BLYAC BMNLL BMXJE BNHUX BROTX BRXPI BSCLL BY8 CS3 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.T H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IH2 IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LH6 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NDZJH NF~ NNB O66 O9- OIG P2P P2W P2X P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RBB RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ SV3 UB1 V8K W8V W99 WBKPD WIB WIH WIK WJL WNSPC WOHZO WQJ WRC WSB WXSBR WYISQ XG1 XPP XV2 ZGI ZXP ZZTAW ~IA ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c3592-f4ebcf50bb15c9e71c09a0796ed7cbd79a7983f693366dcb986a4d152921d6813 |
IEDL.DBID | DR2 |
ISSN | 0730-2312 |
IngestDate | Fri Aug 16 12:21:14 EDT 2024 Fri Aug 23 01:01:02 EDT 2024 Sat Sep 28 07:48:08 EDT 2024 Sat Aug 24 00:56:59 EDT 2024 Wed Oct 30 09:50:56 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
License | Copyright 2002 Wiley-Liss, Inc. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3592-f4ebcf50bb15c9e71c09a0796ed7cbd79a7983f693366dcb986a4d152921d6813 |
Notes | National Health and Medical Research Council of Australia ark:/67375/WNG-X9R2F4CL-R istex:382F899DF40DBD4AB4B35EC270B3BF63BEE4784B ArticleID:JCB10152 NSW State Department of Health ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 11967988 |
PQID | 71718219 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_71718219 crossref_primary_10_1002_jcb_10152 pubmed_primary_11967988 wiley_primary_10_1002_jcb_10152_JCB10152 istex_primary_ark_67375_WNG_X9R2F4CL_R |
PublicationCentury | 2000 |
PublicationDate | 2002 2002-00-00 2002-01-00 20020101 |
PublicationDateYYYYMMDD | 2002-01-01 |
PublicationDate_xml | – year: 2002 text: 2002 |
PublicationDecade | 2000 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: United States |
PublicationTitle | Journal of cellular biochemistry |
PublicationTitleAlternate | J. Cell. Biochem |
PublicationYear | 2002 |
Publisher | Wiley Subscription Services, Inc., A Wiley Company |
Publisher_xml | – name: Wiley Subscription Services, Inc., A Wiley Company |
References | Stebbins CE, Kaelin WG Jr, Pavletich NP. 1999. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science 284(5413): 455-461. Lee S, Chen DY, Humphrey JS, Gnarra JR, Linehan WM, Klausner RD. 1996. Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density. Proc Natl Acad Sci USA 93(5): 1770-1775. Scarpati EM, DiCorleto PE. 1996. Identification of a thrombin response element in the human platelet-derived growth factor B-chain (c-sis) promoter. J Biol Chem 271(6): 3025-3032. Mukhopadhyay D, Knebelmann B, Cohen HT, Ananth S, Sukhatme VP. 1997. The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vacular endothelial growth factor promoter activity. Mol Cell Biol 17(9): 5629-5639. Cohen HT, Zhou M, Welsh AM, Zarghamee S, Scholz H, Mukhopadhyay D, Kishida T, Zbar B, Knebelmann B, Sukhatme VP. 1999. An important von Hippel-Lindau tumor suppressor domain mediates Sp1-binding and self-association. Biochem Biophys Res Commun 266(1): 43-50. Foster K, Prowse A, van den Berg A, Fleming S, Hulsbeek MM, Crossey PA, Richards FM, Cairns P, Affara NA, Ferguson-Smith MA. 1994. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma. Hum Mol Genet 3(12): 2169-2173. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L. 1993. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260(5112): 1317-1320. Pal S, Claffey KP, Cohen HT, Mukhopadhyay D. 1998. Activation of Sp1-mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase C zeta. J Biol Chem 273(41): 26277-26280. Ivan M, Kaelin WG Jr. 2001. The von Hippel-Lindau tumor suppressor protein. Curr Opin Genet Dev 11(1): 27-34. Siemeister G, Weindel K, Mohrs K, Barleon B, Martiny-Baron G, Marme D. 1996. Eversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res 56(10): 2299-2301. Duan DR, Humphrey JS, Chen DY, Weng Y, Sukegawa J, Lee S, Gnarra JR, Linehan WM, Klausner RD. 1995. Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations. Proc Natl Acad Sci USA 92(14): 6459-6463. Trejo SR, Fahl WE, Ratner L. 1996. c-sis/PDGF-B promoter transactivation by the Yax protein of human T-cell leukemia virus type 1. J Biol Chem 271(24): 14581-14590. Crossey PA, Richards FM, Foster K, Green JS, Prowse A, Latif F, Lerman MI, Zbar B, Affara NA, Ferguson-Smith MA, Maher ER. 1994. Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Hum Mol Genet 3(8): 1303-1308. Silverman ES, Khachigian LM, Lindner V, Williams AJ, Collins T. 1997. Inducible PDGF A-chain transcription in smooth muscle cells is mediated by Egr-1 displacement of Sp1 and Sp3. Am J Pathol 273(3 Pt 2): H1415-H1426. Liang Y, Robinson DF, Dennig J, Suske G, Fahl WE. 1996. Transcriptional regulation of the SIS/PDGF-B gene in human osteosarcoma cells by the Sp family of transcription factors. J Biol Chem 271(20): 11792-11797. Khachigian LM, Fries JW, Benz MW, Bonthron DT, Collins T. 1994. Novel cis-acting elements in the human platelet-derived growth factor B-chain core promoter that mediate gene expression in cultured vascular endothelial cells. J Biol Chem 269(36): 22647-22656. Iliopoulos O, Levy AP, Jiang C, Kaelin WG Jr, Goldberg MA. 1996. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci USA 93(20): 10595-10599. Lee S, Neumann M, Stearman R, Stauber R, Pause A, Pavlakis GN, Klausner RD. 1999. Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein. Mol Cell Biol 19(2): 1486-1497. 1995; 92 1994; 269 1999; 19 1997; 273 1993; 260 1996; 93 1996; 271 1997; 17 1999; 284 1999; 266 2001; 11 1994; 3 1996; 56 1998; 273 Trejo SR (e_1_2_6_19_1) 1996; 271 e_1_2_6_10_1 Lee S (e_1_2_6_11_1) 1999; 19 Silverman ES (e_1_2_6_17_1) 1997; 273 e_1_2_6_9_1 Siemeister G (e_1_2_6_16_1) 1996; 56 Mukhopadhyay D (e_1_2_6_13_1) 1997; 17 e_1_2_6_5_1 e_1_2_6_4_1 e_1_2_6_7_1 e_1_2_6_6_1 Khachigian LM (e_1_2_6_8_1) 1994; 269 e_1_2_6_14_1 e_1_2_6_3_1 e_1_2_6_2_1 e_1_2_6_12_1 e_1_2_6_18_1 e_1_2_6_15_1 |
References_xml | – volume: 93 start-page: 10595 issue: 20 year: 1996 end-page: 10599 article-title: Negative regulation of hypoxia‐inducible genes by the von Hippel‐Lindau protein publication-title: Proc Natl Acad Sci USA – volume: 19 start-page: 1486 issue: 2 year: 1999 end-page: 1497 article-title: Transcription‐dependent nuclear‐cytoplasmic trafficking is required for the function of the von Hippel‐Lindau tumor suppressor protein publication-title: Mol Cell Biol – volume: 3 start-page: 2169 issue: 12 year: 1994 end-page: 2173 article-title: Somatic mutations of the von Hippel‐Lindau disease tumour suppressor gene in non‐familial clear cell renal carcinoma publication-title: Hum Mol Genet – volume: 269 start-page: 22647 issue: 36 year: 1994 end-page: 22656 article-title: Novel cis‐acting elements in the human platelet‐derived growth factor B‐chain core promoter that mediate gene expression in cultured vascular endothelial cells publication-title: J Biol Chem – volume: 271 start-page: 11792 issue: 20 year: 1996 end-page: 11797 article-title: Transcriptional regulation of the SIS/PDGF‐B gene in human osteosarcoma cells by the Sp family of transcription factors publication-title: J Biol Chem – volume: 3 start-page: 1303 issue: 8 year: 1994 end-page: 1308 article-title: Identification of intragenic mutations in the von Hippel‐Lindau disease tumour suppressor gene and correlation with disease phenotype publication-title: Hum Mol Genet – volume: 273 start-page: 26277 issue: 41 year: 1998 end-page: 26280 article-title: Activation of Sp1‐mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase C zeta publication-title: J Biol Chem – volume: 271 start-page: 3025 issue: 6 year: 1996 end-page: 3032 article-title: Identification of a thrombin response element in the human platelet‐derived growth factor B‐chain (c‐sis) promoter publication-title: J Biol Chem – volume: 271 start-page: 14581 issue: 24 year: 1996 end-page: 14590 article-title: c‐sis/PDGF‐B promoter transactivation by the Yax protein of human T‐cell leukemia virus type 1 publication-title: J Biol Chem – volume: 273 start-page: H1415 issue: 3 Pt 2 year: 1997 end-page: H1426 article-title: Inducible PDGF A‐chain transcription in smooth muscle cells is mediated by Egr‐1 displacement of Sp1 and Sp3 publication-title: Am J Pathol – volume: 11 start-page: 27 issue: 1 year: 2001 end-page: 34 article-title: The von Hippel‐Lindau tumor suppressor protein publication-title: Curr Opin Genet Dev – volume: 17 start-page: 5629 issue: 9 year: 1997 end-page: 5639 article-title: The von Hippel‐Lindau tumor suppressor gene product interacts with Sp1 to repress vacular endothelial growth factor promoter activity publication-title: Mol Cell Biol – volume: 260 start-page: 1317 issue: 5112 year: 1993 end-page: 1320 article-title: Identification of the von Hippel‐Lindau disease tumor suppressor gene publication-title: Science – volume: 266 start-page: 43 issue: 1 year: 1999 end-page: 50 article-title: An important von Hippel‐Lindau tumor suppressor domain mediates Sp1‐binding and self‐association publication-title: Biochem Biophys Res Commun – volume: 92 start-page: 6459 issue: 14 year: 1995 end-page: 6463 article-title: Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations publication-title: Proc Natl Acad Sci USA – volume: 284 start-page: 455 issue: 5413 year: 1999 end-page: 461 article-title: Structure of the VHL‐ElonginC‐ElonginB complex: implications for VHL tumor suppressor function publication-title: Science – volume: 56 start-page: 2299 issue: 10 year: 1996 end-page: 2301 article-title: Eversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel‐Lindau tumor suppressor protein publication-title: Cancer Res – volume: 93 start-page: 1770 issue: 5 year: 1996 end-page: 1775 article-title: Nuclear/cytoplasmic localization of the von Hippel‐Lindau tumor suppressor gene product is determined by cell density publication-title: Proc Natl Acad Sci USA – ident: e_1_2_6_10_1 doi: 10.1073/pnas.93.5.1770 – volume: 56 start-page: 2299 issue: 10 year: 1996 ident: e_1_2_6_16_1 article-title: Eversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel‐Lindau tumor suppressor protein publication-title: Cancer Res contributor: fullname: Siemeister G – volume: 273 start-page: H1415 issue: 3 year: 1997 ident: e_1_2_6_17_1 article-title: Inducible PDGF A‐chain transcription in smooth muscle cells is mediated by Egr‐1 displacement of Sp1 and Sp3 publication-title: Am J Pathol contributor: fullname: Silverman ES – ident: e_1_2_6_12_1 doi: 10.1074/jbc.271.20.11792 – volume: 271 start-page: 14581 issue: 24 year: 1996 ident: e_1_2_6_19_1 article-title: c‐sis/PDGF‐B promoter transactivation by the Yax protein of human T‐cell leukemia virus type 1 publication-title: J Biol Chem doi: 10.1074/jbc.271.24.14584 contributor: fullname: Trejo SR – ident: e_1_2_6_18_1 doi: 10.1126/science.284.5413.455 – volume: 17 start-page: 5629 issue: 9 year: 1997 ident: e_1_2_6_13_1 article-title: The von Hippel‐Lindau tumor suppressor gene product interacts with Sp1 to repress vacular endothelial growth factor promoter activity publication-title: Mol Cell Biol doi: 10.1128/MCB.17.9.5629 contributor: fullname: Mukhopadhyay D – ident: e_1_2_6_9_1 doi: 10.1126/science.8493574 – ident: e_1_2_6_15_1 doi: 10.1074/jbc.271.6.3025 – ident: e_1_2_6_3_1 doi: 10.1093/hmg/3.8.1303 – volume: 19 start-page: 1486 issue: 2 year: 1999 ident: e_1_2_6_11_1 article-title: Transcription‐dependent nuclear‐cytoplasmic trafficking is required for the function of the von Hippel‐Lindau tumor suppressor protein publication-title: Mol Cell Biol doi: 10.1128/MCB.19.2.1486 contributor: fullname: Lee S – ident: e_1_2_6_7_1 doi: 10.1016/S0959-437X(00)00152-0 – ident: e_1_2_6_6_1 doi: 10.1073/pnas.93.20.10595 – ident: e_1_2_6_5_1 doi: 10.1093/hmg/3.12.2169 – volume: 269 start-page: 22647 issue: 36 year: 1994 ident: e_1_2_6_8_1 article-title: Novel cis‐acting elements in the human platelet‐derived growth factor B‐chain core promoter that mediate gene expression in cultured vascular endothelial cells publication-title: J Biol Chem doi: 10.1016/S0021-9258(17)31695-2 contributor: fullname: Khachigian LM – ident: e_1_2_6_14_1 doi: 10.1074/jbc.273.41.26277 – ident: e_1_2_6_4_1 doi: 10.1073/pnas.92.14.6459 – ident: e_1_2_6_2_1 doi: 10.1006/bbrc.1999.1767 |
SSID | ssj0009932 |
Score | 1.7829885 |
Snippet | VHL is the causative gene for von Hippel‐Lindau disease and sporadic clear cell renal cancer. It has been shown that pVHL can suppress the expression of... VHL is the causative gene for von Hippel-Lindau disease and sporadic clear cell renal cancer. It has been shown that pVHL can suppress the expression of... Abstract VHL is the causative gene for von Hippel‐Lindau disease and sporadic clear cell renal cancer. It has been shown that pVHL can suppress the expression... |
SourceID | proquest crossref pubmed wiley istex |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 490 |
SubjectTerms | Animals Binding Sites Cells, Cultured Chloramphenicol O-Acetyltransferase - genetics Chloramphenicol O-Acetyltransferase - metabolism Down-Regulation gene expression Gene Expression Regulation - physiology Ligases - genetics Ligases - metabolism Muscle, Smooth, Vascular - cytology Muscle, Smooth, Vascular - physiology platelet-derived growth factor B-chain Promoter Regions, Genetic Proto-Oncogene Proteins c-sis - genetics Proto-Oncogene Proteins c-sis - metabolism Rats Rats, Inbred WKY Recombinant Proteins - genetics Recombinant Proteins - metabolism Repressor Proteins - genetics Repressor Proteins - metabolism Sp1 Transcription Factor - metabolism transcription Transcription, Genetic Transfection Tumor Suppressor Proteins Ubiquitin-Protein Ligases von Hippel-Lindau protein Von Hippel-Lindau Tumor Suppressor Protein |
Title | von Hippel-Lindau tumor suppressor protein represses platelet-derived growth factor B-chain gene expression via the Sp1 binding element in the proximal PDGF-B promoter |
URI | https://api.istex.fr/ark:/67375/WNG-X9R2F4CL-R/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjcb.10152 https://www.ncbi.nlm.nih.gov/pubmed/11967988 https://search.proquest.com/docview/71718219 |
Volume | 85 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELaqIgQXfgqU8GshhLikzY8Tx-LEbtmuKqjQQsUekCzbcWhom42yyapw4hF4E96JJ2Fsb3ZVBBLiZsV24tifPTPJzDcIPQ1klqlcF74w8VskK2JfgKT24RrISy1IbHkL3hym4yNyME2mG-hFHwvj-CFWH9zMzrDntdngQs5316Shn5U0pmdizt8wpsada2-ypo4CuWv_IACCfdBhop5VKIh2Vz0vyKJLZlrP_6RoXtRbreAZXUcf-yE7f5OTna6VO-rrb2yO__lON9C1pUKKXzoE3UQbutpCl12Kyi9b6Mqwzwh3C_1YzCo8Lutan_789t1a8x1uu7NZg-ddbT1qoWiZH8oKN87HVs9xfQoKLeADOuUA-IXO8Sew_ttj7LL94AHUqGMBnQDOGuvzpXduhRelwKCi4nd1iGVpI3Cwdh7vGJqbKjMx5Rm8wtu9_RHcaGCuAAB1cxsdjV69H479ZcIHX8UJi_yCaKmKJJAyTBTTNFQBEwFlqc6pkjllgrIsLlIWx2maK8myVJAcpotFYZ5mYXwHbVazSt9FWFMiaUiUFkFMVCQZSbSJSipkVmSM5B560i89rx2vB3cMzhGHVeB2FTz0zIJi1UI0J8YRjib8w-E-n7JJNCLD13ziocc9ajisifnnIio96-YcrGWw4ELmoW0HpvXT4OwzZHEeem4h8fdh8IPhwBbu_XvT--iqzVtjPxY9QJtt0-mHoD618pHdJ78AF2wbZQ |
link.rule.ids | 315,783,787,1378,4031,27935,27936,27937,46306,46730 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ZbtQwFLWqVqi8sJQtbLUQQrykzeIslnhhpkyHMh2hoRXzgizbcWhom0SZZCg88Qn8Cf_El3DtTGZUBBLizfKSeDn2vbavz0XoqSPiWCYqtbl-v0Xi1Lc5SGob4kBeKk58w1twOA6Hx-RgGkzX0IvuLUzLD7E8cNMzw6zXeoLrA-ndFWvoJyn03jOABXgDpruvHTfsTVbkUSB5zR0CpNigxXgdr5Dj7S6LXpJGG7pjL_6kal7WXI3oGVxHH7pKtxYnpztNLXbk19_4HP-3VTfQtYVOil-2ILqJ1lS-ha60Xiq_bKHNfucU7hb6MS9yPMzKUp39_PbdbOgbXDfnRYVnTWmMaiFoyB-yHFetma2a4fIMdFqACBRKAPNzleCPVfG5PsGtwx_cgxR5wqEQIFphdbEw0M3xPOMYtFT8rnSxyMwjHKxao3cM2XWS7pnsHJrwdm9_AB_q6RjAoKpuo-PBq6P-0F74fLClH1DPTokSMg0cIdxAUhW50qHciWiokkiKJKI8orGfhtT3wzCRgsYhJwl0F_XcJIxd_w5az4tc3UNYRURELpGKOz6RnqAkUPphUiriNKYksdCTbuxZ2VJ7sJbE2WMwCsyMgoWeGVQsc_DqVNvCRQF7P95nUzrxBqQ_YhMLbXewYTAm-tqF56poZgw2zLCJc6mF7rZoWv0Nlj_NF2eh5wYTf68GO-j3TOD-v2fdRpvDo8MRG70ev3mArho3Nubs6CFar6tGPQJtqhaPzaT5BZhVH30 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ZbtQwFLWqViwvLGULWy2EEC9psziLxRMzJR1KGVUDFfOAZNmOQ4e2mSiTjApPfAJ_wj_xJVzbkxkVgYR4ixI7cexj33OT63MReuqJNJW5Klyu92-RtAhdDpbahXNgLxUnodEteDuMB0dkfxyN19CLbi-M1YdYfnDTM8Os13qCV3mxsxIN_SyFdj0jWH83SAzMVzOi0Uo7Cgyv-YUAEHaBxASdrJAX7CyrXjBGG7pfz__ENC8SV2N5suvoY9dmG3Byst02Ylt-_U3O8T9f6ga6tmCk-KWF0E20pspNdMnmqPyyia70u5Rwt9CP-bTEg0lVqdOf374bd77FTXs2rfGsrUxILRwa6YdJiWsbZKtmuDoFRgsAgUo5IH6ucvwJ3P_mGNt0P7gHV-Qxh0qAZ4XV-SI8t8TzCcfAUfG7ysdiYrbgYGVD3jEU15d0x0zO4BUOd_cyuFFPnwEEqvo2Ospeve8P3EXGB1eGEQ3cgighi8gTwo8kVYkvPcq9hMYqT6TIE8oTmoZFTMMwjnMpaBpzkkN30cDP49QP76D1clqqewirhIjEJ1JxLyQyEJRESm9LKkRapJTkDnrSDT2rrLAHsxLOAYNRYGYUHPTMgGJZgtcnOhIuidiH4R4b01GQkf4BGzloq0MNgzHRP114qabtjIG7DC6cTx1014Jp9TRY_LRanIOeG0j8vRlsv98zB_f_vegWuny4m7GD18M3D9BVk8PGfDh6iNabulWPgEo14rGZMr8ANXIeLA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=von+Hippel%E2%80%90Lindau+tumor+suppressor+protein+represses+platelet%E2%80%90derived+growth+factor+B%E2%80%90chain+gene+expression+via+the+Sp1+binding+element+in+the+proximal+PDGF%E2%80%90B+promoter&rft.jtitle=Journal+of+cellular+biochemistry&rft.au=Rafty%2C+Louise+A.&rft.au=Khachigian%2C+Levon+M.&rft.date=2002&rft.pub=Wiley+Subscription+Services%2C+Inc.%2C+A+Wiley+Company&rft.issn=0730-2312&rft.eissn=1097-4644&rft.volume=85&rft.issue=3&rft.spage=490&rft.epage=495&rft_id=info:doi/10.1002%2Fjcb.10152&rft.externalDBID=10.1002%252Fjcb.10152&rft.externalDocID=JCB10152 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0730-2312&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0730-2312&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0730-2312&client=summon |